1167325 MS Medical Forum Banner_v2 2320x1000.jpg

Multiple sclerosis - Patient focus

7 MIN

Multiple Sclerosis Medical Forum – Women with MS: navigating disease management through pregnancy and breastfeeding | June 2022

The Multiple Sclerosis Medical Forum organised by Teva Pharmaceuticals took place virtually on June 22, 2022. The expert faculty - Professor Kerstin Hellwig, Professor Elisabeth Gulowsen Celius and Professor Nikolaos Grigoriadis - dove into the topic of disease management in women with MS during pregnancy and breastfeeding. Prof. Hellwig delivered a presentation on current data and recommendati

Login to register to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

Log In

Not registered yet? Register now

References

  1. Cárdenas-Robledo S, Montalban X. Presented at: ECTRIMS Virtual Congress; October 2021 (invited oral presentation). 

  2. Dimethyl fumarate (TECFIDERA) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/tecfidera-epar-product-information_en.pdf. Accessed December 2022.

  3. Natalizumab (TYSABRI) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/tysabri-epar-product-information_en.pdf.Accessed December 2022.

  4. Teriflunomide (AUBAGIO) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/aubagio-epar-product-information_en.pdf.Accessed December 2022.

  5. Fingolimod (GILENYA) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/gilenya-epar-product-information_en.pdf.Accessed December 2022.

  6. Ocrelizumab (OCREVUS) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/ocrevus-epar-product-information_en.pdf.Accessed December 2022.

  7. Cladribine (MAVENCLAD) SmPC. 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/mavenclad-epar-product-information_en.pdf.Accessed December 2022.

  8. Betaferon SmPC. 2021. Available from: https://www.ema.europa.eu/en/documents/product-information/betaferon-epar-product-information_en.pdf.Accessed December 2022.

  9. WHO. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-feeding. Accessed December 2022.

  10. Ofatumumab SmPC. 2021. Available from: https://www.medicines.org.uk/emc/product/12433/smpc#gref.Accessed December 2022.

  11. Marfia GA, Centonze D, Salvetti M, et al. Front Neurol 2022;13:898741–6.

  12. Almouzain L, Stevenson F, Chard D, et al. Mult Scler J 2021;7:20552173211001571.

  13. Rossi S, Motta C, Studer V, et al. Eur J Neurol 2013;20:87–94.